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Abstract
Background The successful application of gene therapy depends on the
availability of carriers to efficiently deliver genetic material into target cells.
Such efficacy is strongly related to key parameters including serum resistance
and protection of DNA.
Methods The complexes were tested in terms of their biological activity,
in the absence or presence of serum, by following transfection activity.
Interaction with plasma proteins was evaluated by immunoblotting, while
cytotoxicity was assessed by the Alamar Blue assay. Extent of DNA protection
was determined both by using ethidium bromide intercalation and DNase I
digestion assays.
Results Our results show that, depending on the charge ratio and on the
lipid composition, albumin and protamine can be used (either individually or
co-associated) to generate cationic liposome/DNA complexes fulfilling in vivo
requirements, while exhibiting high levels of transfection activity. In the
present work a novel cationic lipid was tested. It was demonstrated that
1-palmitoyl-2-oleoyl-sn-glycero-3-ethylphosphocholine (EPOPC):cholesterol
(Chol) liposomes constitute a very promising carrier for gene delivery as
illustrated by their enhancing effect on transfection, as compared with
DOTAP-containing liposomes. Moreover, the biological activity of EPOPC-
containing complexes is significantly improved upon association of albumin,
even in the presence of 60% serum (namely for the 4/1 lipid/DNA charge
ratio). Nevertheless, our studies also show that transfection activity mediated
by DOTAP-containing complexes can be significantly enhanced upon pre-
condensation of DNA with protamine.
Conclusions Co-association of HSA and protamine to lipoplexes ensures
a high degree of DNA protection and results in high levels of transfection
activity even in the presence of serum. Copyright  2004 John Wiley & Sons,
Ltd.
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interaction; serum resistance; DNA protection
Introduction
Efficient gene delivery into target cells is a critical issue for the success of
gene therapy approaches. Although many efforts have been made to develop
efficient non-viral gene delivery systems, their transfection ability has still to be
Copyright  2004 John Wiley & Sons, Ltd.
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improved. Cationic liposome/DNA complexes, also called
lipoplexes, have become the most applied devices in
studies aimed at developing appropriate non-viral gene
delivery systems [1,2]. These complexes have proven
to be promising approaches in transfecting cells in
tissue culture. However, despite this extensive work
in recent years, which has resulted in remarkable
progress culminating in the use of cationic liposome/DNA
complexes in clinical trials, their in vivo efficiency is still
unsatisfactory [3]. This low efficiency in vivo is due to
some limitations that are associated with these systems,
like their poor levels of transfection as compared with viral
vectors, and the considerable reduction of their biological
activity by serum components [4–6]. However, the
potential advantages of these systems over viral vectors
prompted investigators to optimise their performance by
developing novel formulations. Much effort has been
devoted to the synthesis of new cationic lipids that are
serum-resistant, selection of different helper lipids and
to the use of DNA-condensing agents such as polyamines
and protamines aimed at improving the stability of the
complexes. Association of proteins or fusogenic peptides
has also been show to enhance their biological activity
[7–13].
Besides DOTMA and DOTAP, two of the most
popular cationic lipids, numerous new lipids have
become commercially available for transfection purposes.
One of them is EPOPC, a cationic analogue of
phosphatidylcholine, consisting only of normal cellular
metabolites linked with ester bonds, hence exhibiting a
low toxicity and being well suited for clinical applications
involving gene therapy [3,14,15]. Most of the cationic
liposomes that have been used for transfection are
composed of both cationic and neutral helper lipids.
Helper lipids are known to affect various properties of
cationic liposome/DNA complexes and to play a very
important role in mediating intracellular gene transfer.
Considering intravenous application, when cholesterol
was substituted for DOPE, transfection activity was
significantly improved. This is probably explained by the
difference in the stability between DOPE and cholesterol-
containing lipoplexes in the presence of serum [7,8,16].
Besides lipid composition, the incorporation of other
components in the complexes may also be very impor-
tant in the development of efficient gene delivery sys-
tems. It has already been shown that condensation of
DNA with protamine sulfate confers DNA protection and
improves nuclear translocation of DNA, thus enhancing
gene expression [17–20]. On the other hand, coating
cationic liposomes with albumin, the most abundant
plasma protein, was revealed to be a promising strategy
to overcome the undesired interactions between cationic
liposome/DNA complexes and serum components. More-
over, our previous observations indicated that association
of albumin to the complexes enhances their biological
activity by promoting both internalisation of the com-
plexes and intracellular delivery of DNA [21–24].
In this study, we have combined different strategies
aimed at obtaining stable complexes in biological fluids
and exhibiting high transfection activity. These include
the use of different lipid compositions, pre-condensation
of DNA with protamine and association of albumin to the
lipoplexes. We have evaluated whether the transfection
activity of the resulting complexes could be correlated
with the degree of protection conferred to DNA and with
the extent of lipoplex interaction with serum components.
Overall, these data may be of great relevance for future
in vivo applications.
Materials and methods
Preparation of cationic liposomes and
their complexes with DNA
Small unilamellar cationic liposomes (SUV) were pre-
pared by extrusion of multilamellar liposomes (MLV)
composed of a 1 : 1 (mole ratio) mixture of 1,2-
dioleoyl-3-(trimethylammonium)propane (DOTAP) and
dioleoylphosphatidylethanolamine (DOPE) or choles-
terol (Chol) and from a 1 : 1 (mole ratio) mixture
of 1-palmitoyl-2-oleoyl-sn-glycero-3-ethylphosphocholine
(EPOPC) and Chol. Briefly, lipids (Avanti Polar Lipids,
Alabaster, AL, USA) dissolved in CHCl3 were mixed at
the desired molar ratio and dried under vacuum in a
rotatory evaporator. The dried lipid films were hydrated
with deionised water to a final lipid concentration of 6 mM
and the resulting MLV were then sonicated, for 3 min, and
extruded, 21 times, through two stacked polycarbonate
filters of 50 nm pore diameter using a Liposofast device
(Avestin, Toronto, Canada). The resulting liposomes
(SUV) were then diluted five times with deionised water
and filter-sterilised utilising 0.22 µm pore-diameter filters
(Schleicher & Schuell BioScience, Germany). Lipoplexes
were prepared by sequentially mixing 100 µl of a HEPES-
buffered saline solution (HBS; 100 mM NaCl, 20 mM
HEPES, pH 7.4) with liposomes (whose volume was
dependent on the (+/−) charge ratio) and with 100 µl
of HBS solution containing 1 µg of pCMVluc (VR-1216; a
gift from Dr. P. Felgner, Vical, San Diego, CA, USA). The
mixture was further incubated for 15 min at room temper-
ature. Complexes were also prepared by pre-incubating
liposomes with human serum albumin (HSA; 32 µg/µg of
DNA). This ratio was selected based on previous studies
showing that these conditions led to the highest levels
of transfection [23]. In parallel, DNA was pre-incubated
with protamine at different w/w ratios (0.5, 1, 2, 4 µg
of protamine/µg of DNA). In both cases incubations were
performed for 15 min, at room temperature. Finally, com-
plexes were obtained by mixing both suspensions and
further incubated for 15 min at room temperature.
Physicochemical characterisation of
complexes
Complexes were characterised with respect to their size
using a Coulter N4 Plus (Coulter Corporation, Miami, FL,
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USA). The Coulter N4 Plus is a PCS (photon correlation
spectroscopy)-based technique which uses autocorrela-
tion spectroscopy of scattered laser light to determine its
time-dependent fluctuations resulting from the Brownian
motion of particles in suspension. The light intensity scat-
tered at a given angle is detected by a photo-multiplier
whose output current is passed to an autocorrelator,
which analyses time dependence, determining the rate of
diffusion or Brownian motion of the particles and hence
their size. The detection angle is fixed at 90◦. Complexes
were prepared immediately before analysis. All complexes
showed a polymodal size distribution.
Cells
COS-7 cells (American Type Culture Collection, Rockville,
MD, USA) were maintained at 37 ◦C, under 5% CO2,
in Dulbecco’s modified Eagle’s medium-high glucose
(DMEM-HG; Irvine Scientific, Santa Ana, CA, USA)
supplemented with 10% (v/v) heat-inactivated fetal
bovine serum (FBS; Sigma, St. Louis, MO, USA), penicillin
(100 U/ml), streptomycin (100 µg/ml) and L-glutamine
(4 mM). For transfection, 0.4 × 105 COS-7 cells were
seeded in 1 ml of medium in 48-well culture plates and
used at 50–70% confluence.
Transfection activity
Transfection activity mediated by the complexes was
evaluated as described previously [25,26]. Cells were
rinsed twice with serum-free medium and then covered
with 0.3 ml of DMEM-HG (without serum, unless
indicated otherwise) before lipid-based complexes were
added. The complexes were added gently to cells in a
volume of 0.2 ml per well. After 4 h incubation (in 5%
CO2 at 37 ◦C) the medium was replaced with DMEM-HG
containing 10% FBS, and the cells were incubated for
a further 48 h. The cells were then washed twice with
phosphate-buffered saline (PBS) and 100 µl of lysis buffer
(1 mM DTT, 1 mM EDTA, 25 mM Tris-phosphate (pH
7.8), 8 mM MgCl2, 15% glycerol, 1% (v/v) Triton X-100)
were added to each well. The level of gene expression in
the lysates was evaluated by measuring light production
by luciferase in a Mediators PhL luminometer (Mediators
Diagnostika, Vienna, Austria). The protein content of the
lysates was measured by the Dc protein assay reagent
(Bio-Rad, Hercules, CA, USA) using bovine serum albumin
(BSA) as the standard. The data were expressed as relative
light units (RLU) of luciferase per mg of total cell protein.
Interaction of lipid-based complexes
with plasma proteins
The assay for determining the interaction of cationic
complexes with plasma proteins is based on the retention
of the complexes by a 200 nm Anopore membrane
(Whatman, Kent, UK) and using the protocol described
by Ogris et al. [5]. Following their preparation, the
complexes were incubated with 2% of human plasma
for 30 min at 37 ◦C. The membrane of microcentrifuge
tube filters (Whatman, Kent, UK; 200 nm Anopore
membrane) was saturated with 500 µl BSA (1 mg/ml)
to reduce unspecific interaction of plasma proteins with
the membrane and was washed three times with 500 µl of
HBS solution. The mixture of complexes and plasma was
applied onto the membrane, filtered by centrifugation
at 10 000 g and washed three times with 500 µl HBS.
The residue (complex-bound plasma proteins) was eluted
with 100 µl HBS containing 5% (w/v) SDS. Samples
(eluate) and control (HBS solution treated in the same
way) were diluted ten times with HBS and twice with
sample buffer (100 mM Tris-HCl (pH 6.8), 4% (w/v)
SDS, 20% (v/v) glycerol, 0.2% (w/v) bromphenol blue),
and the associated proteins denaturated in boiling water
for 3 min. Aliquots of the treated samples and control
were then applied onto a 7.5% SDS polyacrylamide gel
and separated at 180 V for 1 h in a Mini-PROTEAN
II electrophoresis cell (Bio-Rad). For immunological
identification of the protein a gel was blotted onto
a Hybond P (PVDF) membrane via semidry blotting
(Bio-Rad) at 15 V for 10 min. Unspecific binding was
blocked by incubating the blot with 5% milk powder in
TBST (2.5 mM Tris-HCl (pH 7.6), 15 mM NaCl, 0.1%
Tween 20) for 2 h at room temperature (RT). The
blots were incubated for 1 h at RT with the antibody
solution (antibodies were diluted in TBST) containing
rabbit anti-human complement C3 (Serotec, Oxford, UK)
1 : 4000. As second antibody, an alkaline phosphatase
(AP) conjugate with goat-anti-rabbit IgG (Amersham
Pharmacia Biotech, Uppsala, Sweden) 1 : 20 000 was
used. After 1 h incubation at RT the blots were washed
several times with TBST and incubated with ECF (alkaline
phosphatase substrate; 20 µl of ECF/cm2 of membrane)
for 5 min at RT and then submitted to fluorescence
detection at 570 nm using a Storm-860 (Molecular
Dynamics, Sunnyvale, CA, USA).
Cell viability assay
Following transfection under the different experimental
conditions, cell viability was accessed by a modified
Alamar Blue assay [27]. The assay measures the redox
capacity of the cells due to the production of metabolites
as a result of cell growth and allows determination of
viability over the culture period without the detachment
of adherent cells. Briefly, 1 ml of 10% (v/v) Alamar Blue
dye in complete DMEM-HG medium was added to each
well 45 h following the initial transfection period (4 h).
After 3 h of incubation at 37 ◦C, 200 µl of the supernatant
were collected from each well and transferred to 96-well
plates. The absorbance at 570 and 600 nm was measured
in a Mediators PhL luminometer (Mediators Diagnostika).
Cell viability (as a percentage of control cells) was
calculated according to the formula (A570 − A600) of
treated cells × 100/(A570 − A600) of control cells.
Copyright  2004 John Wiley & Sons, Ltd. J Gene Med 2004; 6: 681–692.
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Ethidium bromide intercalation assay
The accessibility of ethidium bromide to the DNA
associated with the complexes was evaluated at 37 ◦C,
for 2 min, in a SPEX Fluorolog 2 fluorometer (SPEX
Industries, Edison, NJ, USA) as previously described
[26]. Briefly, EtBr fluorescence was read at excitation and
emission wavelengths of 518 and 605 nm, respectively,
using 1 mm excitation and 2 mm emission slits. The
sample chamber was equipped with a magnetic stirring
device, and the temperature was controlled with a
thermostatted circulating water bath. The fluorescence
scale was calibrated such that the initial fluorescence of
EtBr (20 µl of a 2.5 mM solution added to a cuvette
containing 2 ml HBS solution) was set at residual
fluorescence. The value of fluorescence obtained upon
addition of 1 µg DNA (control) was set as 100%.
Complexes (1 µg DNA) were added to the cuvette
containing 2 ml HBS solution followed by addition of
20 µl of EtBr. The amount of DNA available to interact
with the probe was calculated by subtracting the values of
residual fluorescence from those obtained for the samples
and expressed as the percentage of the control.
Resistance to DNase I action
Resistance of complexes to DNase I (Sigma) was
determined by electrophoresis and spectrofluorimetry.
DNase I was maintained in a buffer solution (50 mM
Tris-HCl (pH 7.5), 10 mM MnCl2, 50 µg/ml BSA).
Complexes were submitted to DNase I action (10 units
DNase I/µg of DNA), during 30 min at 37 ◦C, followed
by inactivation of the enzyme upon incubation with
0.5 M EDTA (1 µl/unit of DNase I). Parallel experiments
were performed by incubating samples under the same
experimental conditions, except that DNase I was
previously inactivated. Electrophoresis was performed
in 1% agarose gel prepared in TBE solution (89 mM
Tris-buffer (pH 8.6), 89 mM boric acid, 2.5 mM EDTA)
and containing 1 µg/ml of EtBr. Following incubation
of the complexes with DNase I (active or inactive),
aliquots corresponding to 200 ng of DNA, to which 5 µl
of loading buffer (15% (v/v) ficoll 400, 0.05% (w/v)
bromphenol blue, 1% (w/v) SDS, 0.1 M EDTA, pH 7.8)
had been previously added, were placed in the gel. The
electrophoresis elapsed, for 1 h and 45 min, applying a
voltage of 100 V [26].
In vivo transfection
Gene expression in vivo was assessed by injecting
plain lipoplexes and HSA-lipoplexes (both containing
EPOPC/cholesterol at a 1 : 1 mole ratio) into 8-week-
old mice (CD-1 mice) via the tail vein in a volume of
300 µl. Plain lipoplexes or HSA-lipoplexes (containing
2.4 mg HSA) were prepared at a charge ratio (+/−)
of 4/1 and contained 75 µg pCMVluc. The organs were
harvested and homogenised 24 h following injection, and
luciferase expression in the supernatant was measured in
a luminometer (Mediators Diagnostika; www.mediators-
int.com) using a standard curve for luciferase activity.
Results
Mean diameter of the lipid-based
complexes
The efficacy of carrier systems to deliver genetic material
into target cells is dependent on their physicochemical
properties, since these are known to affect their stability
and biological activity [28,29].
As illustrated in Table 1, lipoplexes prepared from
DOTAP : Chol and EPOPC : Chol cationic liposomes at
2/1 (+/−) charge ratio exhibited larger mean diame-
ters (approximately 1700 nm) than lipoplexes prepared
with the same composition at 4/1 (+/−) charge ratio. The
association of albumin or both albumin and protamine to
these complexes resulted in a significant increase in their
size. On the other hand, incubation of the different com-
plexes with 60% of serum led to different changes in their
size. For the lipoplexes prepared at the 4/1 (+/−) charge
ratio (in the absence of albumin and protamine), incuba-
tion with 60% serum for 30 min resulted in no significant
size effect. For the complexes prepared at the same (+/−)
charge ratio, but in the presence of albumin or of albumin
and protamine, incubation with 60% serum for 30 min
promoted a significant decrease in their mean diameter. It
should be noted that size measurements were performed
on control samples containing only 60% serum, thus
allowing the elimination of the contribution of serum com-
ponents to the mean diameter distribution determined for
the different lipoplex preparations (data not shown). For
the various conditions tested no major differences were
observed when DOTAP was replaced by EPOPC.
Biological activity of the complexes
Figure 1 illustrates the influence of complex composition
and charge ratio on their biological activity. Transfection
Table 1. Mean diameters of lipid-based complexes
Complexes
Mean
diameter
(nm)
Mean
diameter
(nm) 60% of
serum
DOTAP : Chol/DNA (+/−) (2/1) 1673 (±324) 633 (±286)
DOTAP : Chol/DNA (+/−) (4/1) 255 (±91) 396 (±164)
HSA-DOTAP : Chol/DNA (+/−) (4/1) 2034 (±516) 570 (±260)
HSA-DOTAP : Chol/DNA 4P (+/−) (4/1) 2007 (±430) 821 (±336)
EPOPC : Chol/DNA (+/−) (2/1) 1671 (±406)
EPOPC : Chol/DNA (+/−) (4/1) 440 (±97) 368 (±143)
HSA-EPOPC : Chol/DNA (+/−) (4/1) 2150 (±432) 873 (±392)
HSA-EPOPC : Chol/DNA 4P (+/−) (4/1) 1923 (±568) 448 (±112)
DOTAP : Chol (1 : 1) and EPOPC : Chol (1 : 1) liposomes were prepared as
described in ‘Materials and methods’. The results represent the mean ±
standard deviation of at least three independent experiments.
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studies showed that the biological activity mediated by
lipoplexes was dependent on their charge ratio (+/−) and
on their lipid composition, those prepared at 2/1 (+/−)
charge ratio being the most active independently of the
liposome composition. Among the different formulations,
EPOPC : Chol/DNA complexes were those exhibiting the
highest levels of transfection for all charge ratios tested.
Figure 1 also shows that association of HSA to
DOTAP : Chol/DNA complexes (at the 4/1 (+/−) charge
ratio) led to a slight increase in their biological activ-
ity, while HSA-associated EPOPC : Chol/DNA complexes
exhibited a significantly higher transfection activity for all
charge ratios tested as compared with plain lipoplexes.
For DOTAP : DOPE complexes, an enhancement was only
observed for the 2/1 (+/−) charge ratio. These results
showed that the enhancement of transfection activity
induced by albumin is dependent on the lipid composition
and on the charge ratio of the complexes.
As illustrated in Figure 2, the use of protamine to
pre-condense DNA resulted in an enhancement in trans-
fection activity, this effect being dependent on the amount
of protamine, on the presence or absence of HSA, on
the charge ratio of the complexes, and on the composi-
tion of the liposomes. For DOTAP-containing lipoplexes,
prepared at 2/1 (+/−) charge ratio, pre-condensation
of DNA with increasing amounts of protamine led to a
significant enhancement of transfection activity (up to
2 µg of protamine/µg of DNA; Figure 2A). For higher
protamine/DNA ratios a significant decrease in luciferase
gene expression was observed. It should be emphasised
that this enhancing effect of protamine (namely for the
optimal condition) was essentially abolished when HSA
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Figure 1. Effect of complex composition and charge ratio (+/−)
on luciferase gene expression in COS-7 cells. Cells were rinsed
twice with serum-free medium and then covered with 0.3 ml of
DME-HG before cationic liposome/DNA complexes were added.
The liposomes (DOTAP : Chol, EPOPC : Chol and DOTAP : DOPE),
pre-incubated or not with HSA (32 µg/µg of DNA), were
complexed with 1 µg of pCMVluc at the indicated theoretical
lipid/DNA charge ratios. After an incubation for 4 h, the medium
was replaced with DME-HG containing 10% FBS and the cells
were further incubated for 48 h. The level of gene expression
was evaluated as described in ‘Materials and methods’. The data
are expressed as RLU of luciferase per mg of total cell protein
(mean ± standard deviation obtained from triplicates), and are
representative of three independent experiments
was also present in the complexes. No effect of protamine
on transfection was observed when 4/1 (+/−) complexes
were used, independently of the presence or absence
of HSA.
For EPOPC-containing complexes, prepared both at
2/1 and 4/1 (+/−) charge ratios, a similar pattern
on the enhancement of transfection was observed upon
addition of protamine, except that the highest values of
luciferase gene expression were obtained for the 1 µg
of protamine/µg of DNA ratio. Nevertheless, 2/1 (+/−)
complexes were more active than 4/1 (+/−) complexes
for all the protamine/DNA ratios tested. As opposed to
what was observed for DOTAP-containing complexes,
the transfection activity mediated by EPOPC-containing
complexes was strongly enhanced when albumin was
associated to the complexes in the absence of protamine
(Figure 2B). This enhancing effect is slightly reduced upon
pre-condensation of DNA with 1 µg of protamine, levelling
off for increasing amounts of protamine.
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Figure 2. Effect of the amount of protamine on biological
activity of complexes in COS-7 cells. Cells were rinsed
twice with serum-free medium and then covered with 0.3 ml
of DME-HG before cationic liposome/DNA complexes were
added: (A) complexes prepared with DOTAP : Chol liposomes;
(B) complexes prepared with EPOPC : Chol liposomes. The
liposomes, pre-incubated or not with HSA (32 µg/µg of DNA),
were complexed with 1 µg of pCMVluc, pre-condensed with
different amounts of protamine, at the indicated theoretical
lipid/DNA charge ratios. After an incubation for 4 h, the medium
was replaced with DME-HG containing 10% FBS and the cells
were further incubated for 48 h. The level of gene expression
was evaluated as described in ‘Materials and methods’. The data
are expressed as RLU of luciferase per mg of total cell protein
(mean ± standard deviation obtained from triplicates), and are
representative of three independent experiments
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Effect of serum on transfection activity
Aiming at predicting the in vivo behaviour of the com-
plexes upon their intravenous administration, transfection
studies were performed in the presence of different
amounts of serum. As shown in Figure 3, the biologi-
cal activity of DOTAP : Chol/DNA lipoplexes, prepared at
both 2/1 and 4/1 (+/−) charge ratios, decreased as the
amount of serum was increased up to 60%. Similar results
were observed for EPOPC-containing complexes (data not
shown). Taking these findings into account, transfection
activity mediated by the other formulations developed
in this work was also evaluated in the presence of the
highest serum concentration (60%).
As illustrated in Figure 4, the inhibitory effect of serum
on transfection was essentially abolished upon association
of albumin to EPOPC-containing complexes prepared at
the 4/1 (+/−) charge ratio. Nevertheless, these particular
complexes lost their resistance to serum when DNA was
pre-condensed with increasing amounts of protamine
(1–4 µg of protamine/µg of DNA). In contrast, association
of HSA to DOTAP-containing complexes either at 2/1 or
4/1 charge ratios did not confer any resistance to the
inhibitory effect of serum. Surprisingly, however, pre-
condensation of DNA with protamine completely reversed
this effect. A significant enhancement of transfection
was even observed, as compared with controls (cells
transfected in the absence of serum), for the HSA-
DOTAP : Chol/DNA complexes prepared at the 4/1 (+/−)
charge ratio. Nevertheless for 2/1 (+/−) complexes the
inhibitory effect of serum was maintained, independently
of the amount of associated protamine. It should be noted
that complexes containing protamine, but prepared in the
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Figure 3. Effect of presence of different serum percentages
on luciferase gene expression in COS-7 cells. Cells were
covered with 0.3 ml of DME-HG enriched with FBS, in order
to obtain a final concentration of 10 or 30%, or with 0.3 ml
of FBS, in order to obtain a final concentration of 60%, before
lipid/DNA complexes were added. After an incubation for 4 h,
the medium was replaced with 1 ml of medium containing 10%
FBS and the cells were further incubated for 48 h. The level
of gene expression was evaluated as described in ‘Materials
and methods’. The data are expressed as the percentage of the
RLU of luciferase per mg of total cell protein of the control
(transfection in the absence of serum). The results correspond
to the mean ± standard deviation obtained from triplicates, and
are representative of at least two independent experiments
absence of HSA, lost most of their biological activity (up
to 75%) when transfection was carried out in the presence
of 60% serum (data not shown).
Interaction of the complexes with
plasma proteins
Previous reports have already demonstrated that the
presence of serum can decrease the transfection activity
of the complexes, most likely through interaction with
serum proteins [7–9]. In an attempt to clarify this issue,
the dependence of the extent of this interaction with
certain serum components on the composition of the
complexes was investigated by Western blotting. For
this purpose, an antibody against C3 human complement
protein was used. This protein was investigated because
complement activation involving C3 protein is known to
play a major role in destabilisation and blood clearance
of the complexes [30,31]. Figure 5 shows the bands
corresponding to C3 bound to DOTAP : Chol/DNA and
EPOPC : Chol/DNA complexes upon their incubation with
2% human plasma at 37 ◦C. As can be observed, complexes
composed of DOTAP : Chol/DNA (+/−)(4/1) prepared
with albumin and protamine (4 µg/µg DNA) bound to the
C3 complement protein more extensively than 4/1 (+/−)
DOTAP : Chol/DNA complexes containing only albumin
or than plain complexes. In the same way, the binding
of the C3 complement protein to EPOPC : Chol/DNA
(+/−) (4/1) complexes containing both albumin and
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Figure 4. Effect of presence of serum on luciferase gene
expression in COS-7 cells. Cells were covered with 0.3 ml of
FBS, in order to obtain a final concentration of 60%, before
lipid/DNA complexes were added. After an incubation for 4 h,
the medium was replaced with 1 ml of medium containing 10%
FBS and the cells were further incubated for 48 h. The level
of gene expression was evaluated as described in ‘Materials
and methods’. The data are expressed as the percentage of the
RLU of luciferase per mg of total cell protein of the control
(transfection in the absence of serum). The results correspond
to the mean ± standard deviation obtained from triplicates, and
are representative of at least three independent experiments
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Figure 5. Interaction of cationic liposome/DNA complexes with C3 protein of the human complement. HSA-DOTAP : Chol/DNA-4P
(+/−) (4/1) (1); HSA-DOTAP : Chol/DNA (+/−) (4/1) (2); DOTAP : Chol/DNA (+/−) (4/1) (3); HSA-EPOPC : Chol/DNA-4P (+/−)
(4/1) (4); HSA-EPOPC : Chol/DNA-4P (+/−) (2/1) (5); HSA-EPOPC : Chol/DNA (+/−) (4/1) (6); HSA-EPOPC : Chol/DNA (+/−)
(2/1) (7); EPOPC : Chol/DNA (+/−) (4/1) (8); control (9). Complexes were incubated at 37 ◦C, for 30 min, with human plasma and
C3 were identified by immunoblotting as described in ‘Materials and methods’. Extent of interaction (%), for each experimental
condition, was calculated with respect to the sum of the intensities of the bands for the protein (considered as 100%). The results
are representative of four independent experiments
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Figure 6. Effect of cationic liposome/DNA complexes on the viability of COS-7 cells. Cells were rinsed twice with serum-free medium
and then covered with 0.3 ml of DME-HG or with 0.3 ml of FBS, in order to obtain a final concentration of 60%, before cationic
liposome/DNA complexes were added. After an incubation for 4 h, the medium was replaced with DME-HG containing 10% FBS
and the cells were further incubated for 48 h. Cell viability was measured by the Alamar Blue assay as described in ‘Materials
and methods’. The data are expressed as the percentage of the untreated control cells (mean ± standard deviation obtained from
triplicates), and are representative of two independent experiments
protamine was higher than the binding to complexes with
the same lipid composition, either plain or associated
only to albumin. It was also observed (Figure 5) that
complexes prepared from DOTAP : Chol liposomes bound
more protein than those prepared from EPOPC : Chol
liposomes and that increasing the (+/−) charge ratio
of EPOPC-containing complexes resulted in an increase in
the extent of protein binding.
Evaluation of the cytotoxicity induced
by the complexes
Since the application of cationic liposomes is usually
associated with some cytotoxicity, we performed cell
viability studies for complexes prepared with the highest
amount of lipid used in the present work. The results
showed that low toxicity (16%) was induced upon cell
incubation with complexes produced with both liposome
formulations (DOTAP : Chol and EPOPC : Chol), either
associated or not to albumin and protamine in the absence
of serum. No cytotoxicity was observed when experiments
were performed in the presence of 60% serum (Figure 6).
Protection of DNA associated to the
complexes
Ethidium bromide is a monovalent DNA-intercalating
agent whose fluorescence is dramatically enhanced upon
binding to DNA and quenched when displayed by higher
affinity compounds or by condensation of the DNA
structure. Therefore, this probe has been used to examine
the ability of cationic lipids to protect DNA [32]. Figure 7
shows that EtBr fluorescence decreased with increasing
the (+/−) charge ratio of the complexes, independently
of the cationic liposome formulation used in their
preparation. These results clearly indicate that an increase
in the amount of cationic liposomes led to a higher degree
of DNA condensation and protection as compared with
that observed when complexes were prepared at low
lipid/DNA charge ratios. The incorporation of albumin
into the complexes resulted in a slight increase of the EtBr
access to DNA, while an opposite effect was observed
when both HSA and protamine were associated to the
cationic liposome/DNA complexes. It was also shown
that incubation of the complexes with 60% serum, for
30 min, promoted an increase in the EtBr fluorescence.
Nevertheless, under these conditions, all complexes
Copyright  2004 John Wiley & Sons, Ltd. J Gene Med 2004; 6: 681–692.
688 H. Faneca et al.
prepared at the 4/1 (+/−) charge ratio maintained most
of the carried DNA inaccessible to the probe (Figure 7).
In an attempt to demonstrate the degree of DNA
protection mediated by the cationic liposomes from
degradation by nucleases in vivo, an in vitro DNase I
protection assay was performed. Figure 7 also illustrates
the results obtained upon incubation of the complexes
with active or inactive DNase I. As shown, similar
findings were obtained for the extent of DNA degradation
induced by DNase I and for the access of EtBr to
DNA. DOTAP : Chol/DNA complexes prepared at 4/1
(+/−) charge ratio, with or without albumin, protected
most of their DNA, as reflected by the slight difference
between the intensity of the bands corresponding to
the complexes exposed to inactive and active DNase
I (Figure 7A). Differences between the intensity of
the bands (complexes incubated with inactive and
active DNase I) were practically nonexistent for 4/1
(+/−) DOTAP : Chol/DNA complexes, prepared with both
albumin and protamine, indicating their higher capacity
to protect DNA (Figure 7A). Similar to 4/1 (+/−)
DOTAP : Chol/DNA complexes no major differences were
found in the degree of DNA protection for 4/1 (+/−)
EPOPC : Chol/DNA complexes, independently of the
presence of albumin (Figure 7B). Results on the DNase
I resistance mediated by EPOPC-containing complexes
when prepared in the presence of protamine are not
shown, since the bands corresponding to these complexes
either treated with active or inactive DNase I were barely
detected (even upon lipid extraction). Nevertheless, data
obtained from the assay on the EtBr access to DNA indicate
that the presence of protamine only slightly increased
protection of DNA.
Discussion
Although a correlation between in vitro and in vivo
transfection studies is not frequently straightforward,
exploratory work performed with cell cultures, together
with extensive biophysical characterisation of the
lipoplexes, provides crucial information for the successful
development of novel lipid-based formulations.
In accordance with our previous studies, lipoplexes
prepared at 2/1 (+/−) charge ratio present a slightly pos-
itive charge [26]. Under this condition, the electrostatic
repulsive forces established between the complexes are
minimal, thus favouring the formation of large aggregates
[33,34]. Taking this into account, the smallest complexes
were obtained for positively charged complexes (pre-
pared at 4/1 (+/−) charge ratio), a fact attributed to
the establishment of repulsive forces, that prevent their
aggregation. However, when complexes were prepared
at this lipid/DNA charge ratio and associated with albu-
min and protamine, an increase in the mean diameter
was observed, probably due to the neutralising effect of
the positive charges of the complexes (conferred by the
cationic lipids and protamine) by albumin (which exhibits
a net negative charge) [23].
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Figure 7. Access of ethidium bromide and resistance to DNase I
of DNA associated with the complexes. Complexes prepared with
(A) DOTAP : Chol liposomes and (B) EPOPC : Chol liposomes,
containing 1 µg of DNA, were incubated with EtBr as described
in ‘Materials and methods’. The amount of DNA available to
interact with the probe was calculated by subtracting the
values of residual fluorescence from those obtained for the
samples and expressed as the percentage of the control. Control
corresponds to free DNA, but in the same amount as that
associated with the complexes (100% of EtBr accessibility).
The results correspond to the mean ± standard deviation
obtained from independent triplicates. For the resistance to
DNase I complexes were incubated with inactive DNase I
(odd numbers) or with active DNase I (even numbers), the
incubation being performed at 37 ◦C, for 30 min, using 10
units DNase I per µg of DNA. Control corresponds to the
free DNA, but in the same amount as that associated with
the complexes. (A) Control (1 and 2); DOTAP : Chol/DNA (+/−)
(4/1) (3 and 4); HSA-DOTAP : Chol/DNA (+/−) (4/1) (5
and 6); HSA-DOTAP : Chol/DNA-4P (+/−) (4/1) (7 and 8).
(B) Control (1 and 2); EPOPC : Chol/DNA (+/−) (4/1) (3 and 4);
HSA-EPOPC : Chol/DNA (+/−) (4/1) (5 and 6). Electrophoresis
was performed in 1% agarose gel prepared in TBE solution
and containing 1 µg/ml of EtBr as described in ‘Materials and
methods’. The results are representative of three independent
experiments
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Independently of the lipid composition, lipoplexes
prepared at the 2/1 (+/−) charge ratio were those
exhibiting the highest capacity of transfection. The larger
size of these complexes may, at least partially, justify
this result, due to their tendency to sediment over
the cells, thus promoting cell internalisation. Besides
the enhanced interaction of large complexes with cells,
it should be considered that these complexes carry a
large number of DNA copies, which can also explain
the high levels of transfection observed [17,28,35,36].
In addition to the size, the surface charge of the
complexes may also play a relevant role, since complexes
with a positive zeta potential (2/1 and 4/1 (+/−))
mediated a higher transfection activity than complexes
with a negative zeta potential (1/1 (+/−)). This can
be due to the extensive interaction of the positively
charged complexes with the negatively charged cell
membrane [26,32,37]. However, our results indicated,
in agreement with previous reports, that the composition
of the complexes also plays a very important role in
their biological activity [7,26,38]. Complexes prepared
from the EPOPC : Chol liposomes exhibited a higher
biological activity than the complexes prepared from
the other liposome formulations tested in the same
charge ratio (+/−), in spite of having approximately
the same mean diameter and zeta potential. The effect of
liposome composition on transfection activity was still
more remarkable upon incorporation of albumin and
protamine. It should be emphasised that the enhancement
of the biological activity induced by these components
cannot be attributed to changes in the mean diameter and
zeta potential of the complexes.
In the case of albumin, although the exact mechanism
of the enhancement of gene delivery and expression
by HSA-lipoplexes is not known, previous experiments
performed in our laboratory indicate that the endocytotic
pathway is involved [23]. In agreement with other reports,
these experiments showed that the HSA-lipoplexes could
bind non-specifically to cell surface receptors, analogous
to scavenger receptors, which in turn mediate their
endocytosis, resulting in a transfection enhancement
[21–24]. Moreover, albumin can facilitate the escape
of DNA from the endocytotic pathway, since albumin
has been described as being able to undergo a low
pH-induced conformational change, thereby acquiring
fusogenic properties [39–41]. However, this capacity of
albumin to induce fusion is sensitive to the nature of
the lipids, which may explain the dependence of the
enhancing effect of albumin on the liposome composition
[39]. Thus, the partial protonation of HSA at endosomal
pH and its subsequent interaction with the endosome
membrane may be involved in the destabilisation of
the latter. This destabilisation may then promote the
transbilayer movement (flip-flop) of anionic lipids from
the cytoplasmic leaflet of the endosome membrane to
the lumenal leaflet [23]. The anionic lipids may then
mediate the dissociation of the lipoplex and the entry of
the DNA into the cytoplasm, as suggested by Xu and Szoka
[32]. It is also possible that the conformational change of
albumin, involving a reversible expansion of the protein,
reinforces the dissociation of the complexes promoted by
lipid flip-flop. All these processes may contribute to the
improvement in the biological activity of these complexes
induced by albumin.
On the other hand, the enhancing effect of protamine
on transfection is probably due to its capacity to condense
DNA into a compact structure, which can improve DNA
stability and favour its uptake by the cells as well as its
nuclear entry [17–19].
Quite frequently, lipofection efficiency decreases drasti-
cally by the addition of serum to the transfection medium.
Although in in vitro studies inactivation by serum can be
circumvented by incubating the cells with the complexes
in serum-free medium, this approach cannot obviously be
applied in vivo. This shortcoming limits the use of cationic
liposomes in in vivo gene delivery, namely considering
systemic administration.
Our results showed that cationic liposome/DNA
complexes prepared with only protamine at any (+/−)
charge ratio lost most of their biological activity in the
presence of serum at a final concentration of 60%. This
might be explained by the dissociation process of the
complexes and/or the formation of large aggregates
promoted by serum proteins (such as C3 protein of
the complement) that bind to the complexes [38,42].
However, in agreement with other authors, the inhibition
of transfection activity depends not only on the extent
of binding of serum proteins to the complexes, but also
on the complex composition [25,43–45]. In fact, in our
study, it was observed that 4/1 (+/−) DOTAP : Chol/DNA
complexes with HSA and protamine (4 µg/µg of DNA) and
4/1 (+/−) EPOPC : Chol/DNA complexes with HSA, in
spite of binding much larger amounts of serum proteins
than complexes prepared in the absence of HSA and
protamine, were shown to exhibit resistance to inhibition
by serum (up to 60%). The observed resistance can be
attributed to the ability of certain lipids to overcome the
inhibitory effect of serum and/or to different structural
reorganisation within the complexes induced by serum,
which may be dependent on their composition [46,47].
It is also possible that association of some serum
components (e.g. proteins) to the complexes promotes
their entry into cells via endocytosis and/or plays a role
in facilitating intracellular DNA delivery [43,48–50].
Despite the high transfection activity observed in vitro
for 4/1 (+/−) DOTAP : Chol/DNA complexes associated
with albumin and protamine (4 µg/µg of DNA), the high
extent of binding of the C3 protein to these complexes
can limit their in vivo use, since this protein is known to
play a major role in opsonisation [30,31]. In this regard,
albumin-associated EPOPC : Chol/DNA complexes may
constitute a promising candidate for in vivo gene delivery,
since, in addition to their high biological activity in the
presence of serum, their low ability to interact with serum
proteins predicts that they will be stable in circulation
[8,51]. Our preliminary results strongly suggest that
albumin-associated lipoplexes are significantly more
efficient in mediating in vivo transfection than plain
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lipoplexes (Figure 8). Upon intravenous administration
of the complexes, the lung is the organ where the
highest levels of transfection have been observed, thus
hampering that other organs can be reached. This can be
most likely attributed to the large size of the complexes
(for in vivo applications, a high concentration of DNA
and lipid is needed resulting in an increase in the
size of the complexes), indicating that further work
is required to optimise their final size. However, the
albumin-enhancing effect is particularly relevant in the
heart of mice, since in its absence no transfection was
observed, this behaviour not being attributed to any
retention effect. The preliminary in vivo studies reinforce
the potential of EPOPC-containing formulations for in vivo
gene delivery, since a 500-fold enhancement in the levels
of gene expression in the lung was observed as compared
with similar formulations but containing DOTAP [23].
Cytotoxicity results indicate that no major effects
on cell viability were observed upon transfection with
the different formulations tested. Therefore, differences
in transfection activity among the various formulations
tested cannot be attributed to cytotoxic effects. It should
be noted that the presence of serum totally abolished the
low levels of cell toxicity observed. This may be related,
not only to better cell growing conditions, but also to the
fact that the presence of serum may reduce the strong
tendency of the complexes to aggregate and to sediment
over the cells [43].
The studies on the access of EtBr to DNA indicate that
for the 1/2 (+/−) charge ratio complexes a significant
amount of DNA (approximately 75%) is exposed. Elec-
tron microscopy studies performed with cationic lipo-
some/DNA complexes, for which 65% of DNA was avail-
able to EtBr intercalation, indicate that these complexes
exhibit a structure where DNA can be detected, suggest-
ing that part of it is free and non-condensed [52]. On the
other hand, the observed reduced DNA intercalation of
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Figure 8. In vivo transfection by plain lipoplexes and HSA-
lipoplexes. Plain lipoplexes and HSA-lipoplexes (both at a charge
ratio (+/−) of 4/1 and containing 75 µg pCMVluc) were injected
into mice via the tail vein in a volume of 300 µl. Luciferase gene
expression in the lungs and heart was measured 24 h following
injection, and is given as pg of luciferase/mg of tissue. The
results correspond to the mean ± standard deviation obtained
from three animals
EtBr for complexes prepared at the 2/1 and 4/1 lipid/DNA
charge ratios shows that DNA is condensed and almost
completely protected. However, association of albumin
resulted in a slight decrease of DNA protection. In con-
trast, incorporation of protamine leads to a reduction in
the amount of exposed DNA, showing the condensing and
protective capacity of this peptide [17,18]. Our findings
show that serum proteins bind avidly to some of the com-
plexes tested, which may lead to changes in their structure
[38,47]. Therefore, the effect of serum on the DNA expo-
sure was evaluated. Our results show that incubation of
the complexes with 60% serum promoted a decrease in
DNA condensation, although, for complexes prepared at
the 4/1 (+/−) charge ratio, most of the DNA remained
protected. This indicates that complexes that are biologi-
cally active in the presence of serum maintain most of their
DNA protected, independently of the structural reorgani-
sation induced by serum. Studies on DNA protection were
complemented using DNase I degradation assays, which
are more biologically relevant in demonstrating the abil-
ity of the complexes to protect DNA than the EtBr access
assay [53]. The results obtained indicate that cationic lipo-
some/DNA complexes prepared at 4/1 (+/−) charge ratio
ensure a high degree of DNA protection, this being almost
complete when DNA was pre-condensed with protamine.
The ability of the cationic liposome/DNA complexes to
exhibit serum resistance and to protect DNA are two of
the major requirements for in vivo applications. Although
a direct extrapolation of transfection efficiency of the
complexes from in vitro to in vivo is not straightforward,
in vitro studies of transfection performed in the presence
of serum may serve as a predictive model for in vivo
transfection efficiency of these systems. In this context,
our results suggest that, depending on the charge ratio
and on the lipid composition, albumin and protamine can
be used to produce cationic liposome/DNA complexes
that can efficiently protect DNA, while exhibiting a high
biological activity in the presence of serum.
Overall, our results demonstrate that EPOPC consti-
tutes a very promising cationic lipid for gene delivery
purposes as illustrated by its enhancing effect on trans-
fection, as compared with DOTAP-containing lipoplexes.
Moreover, the biological activity of EPOPC-containing
complexes is significantly improved upon association of
albumin, even in the presence of 60% serum (namely
for the 4/1 lipid/DNA charge ratio). Nevertheless, our
studies also show that transfection activity mediated
by DOTAP-containing complexes can be significantly
enhanced upon pre-condensation of DNA with protamine.
Co-association of HSA and protamine resulted in com-
plexes exhibiting high levels of transfection activity in the
presence of serum.
Based on these observations, the formulations devel-
oped in this work are promising candidates for in vivo use.
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